Cellectar Biosciences's total assets for Q4 2024 were $25.47M, a decrease of -31.69% from the previous quarter. CLRB total liabilities were $11.18M for the fiscal quarter, a -49.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.